NewAms­ter­dam says for­mer Am­gen car­dio drug re­duces heart dis­ease risk fac­tor

A Dutch biotech has proved its res­ur­rect­ed Am­gen drug is ca­pa­ble of sig­nif­i­cant­ly low­er­ing “bad” cho­les­terol in a hand­ful of mid-stage tri­als in re­cent years …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER